Among the 70 patients with BRCA1 LGR, patients with ovarian cancer accounted for the largest proportion (33/70, 47.1%), followed by breast cancer (12/70, 17.1%) and lung cancer (9/70, 12.9%). This evidence concerns the gene BRCA1 and lung cancer.